A detailed history of Strs Ohio transactions in Ardelyx, Inc. stock. As of the latest transaction made, Strs Ohio holds 27,500 shares of ARDX stock, worth $176,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,500
Holding current value
$176,825
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$5.89 - $9.31 $161,975 - $256,025
27,500 New
27,500 $203,000
Q2 2023

Jul 31, 2023

BUY
$3.23 - $4.95 $126,293 - $193,545
39,100 New
39,100 $132,000
Q3 2021

Oct 22, 2021

SELL
$1.27 - $8.17 $14,122 - $90,850
-11,120 Closed
0 $0
Q3 2020

Dec 14, 2020

SELL
$5.25 - $7.08 $56,175 - $75,756
-10,700 Reduced 49.04%
11,120 $58,000
Q2 2020

Jul 23, 2020

SELL
$5.37 - $8.11 $130,920 - $197,721
-24,380 Reduced 52.77%
21,820 $150,000
Q4 2019

Jan 24, 2020

BUY
$4.23 - $8.29 $195,426 - $382,997
46,200 New
46,200 $346,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $994M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.